Evaluation of clinical effectiveness of buffered and nonbuffered 4% articaine infiltration for primary maxillary molar extraction.
Not Applicable
- Conditions
- Health Condition 1: K027- Dental root cariesHealth Condition 2: K027- Dental root caries
- Registration Number
- CTRI/2022/01/039457
- Lead Sponsor
- Dr Parag Sadashiv Dhake
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children Having at least one primary maxillary molar indicated for extraction
under local anaesthetic.
Children who exhibited Franklââ?¬•s behavior rating grade three or four i.e positive
and definitely positive.
Exclusion Criteria
Children with active infection at the site of injection.
Children with known history of allergy to any local anaesthetic agent.
History of major dental treatment in last 6 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does buffering affect articaine's sodium channel block in maxillary infiltration for dental procedures?
What is the efficacy comparison of buffered vs. nonbuffered 4% articaine with adrenaline in primary maxillary molar extractions?
What are the key findings of CTRI/2022/01/039457 regarding biomarkers for articaine response in pediatric dental anesthesia?
What adverse events are associated with buffered vs. nonbuffered articaine in maxillary infiltration and their management strategies?
How does 4% articaine with adrenaline compare to other amide anesthetics in pediatric dental procedures for pain control?